Avalun takes part in the next generation of POC testing

As a young innovative company, our ambition is to address one of the main challenges for tomorrow’s medicine: to make available, here and now, the biological parameters that patients and healthcare professionals need. Because we put patients first, we focus all our energy on developing our next-generation LabPad® POC testing device and its associated Tsmart® range of microcuvettes.

Avalun is a spin-off company from the top French research center CEA/Leti. Our project started off there after a meeting with Vincent Poher, a specialist in photonics with a PhD from the Imperial College of London, and Patrick Pouteau, a researcher involved for more than 15 years in the development of health-related microsystems. Understanding the amazing potential of patented lensless imaging technology to satisfy unmet needs for point-of-care patient testing, they together designed an initial prototype with the objective of helping to improve our healthcare systems. In June 2013, the project was awarded by the French Ministry of Higher Education and Research, and Avalun, from the Greek "ἀνάλυσις" or "analysis", was founded in November of the same year.

Today, our multidisciplinary team consists of 20 dedicated individuals providing their unique expertise and sharing the same passion for innovation and health care. Driven by our quality system, our values are excellence, commitment, and responsibility.

About Avalun

Ever since it was founded, Avalun has focused its efforts on developing LabPad®, a connected Handy Lab designed to address the needs for multiparametric near-patient testing.

Innovative medical device
INR auto-test
INR blood test
POC testing

PT/INR meters
PT/INR monitoring system
PT/INR self-testing
PT/INR test
Warfarin monitoring


Avalun SAS
7 Parvis Louis Néel